4883 — Modalis Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Modalis Therapeutics, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -745 | -2,707 | -2,391 | -1,317 | -2,151 |
| Depreciation | |||||
| Non-Cash Items | -487 | 678 | 40.9 | -20.9 | 34.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 407 | 9.51 | 94.5 | -94.2 | -2.06 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -747 | -1,896 | -2,254 | -1,432 | -2,118 |
| Capital Expenditures | -107 | -197 | -39.7 | -0.188 | -2.57 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 279 | 11.6 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 172 | -186 | -39.7 | -0.188 | -2.57 |
| Financing Cash Flow Items | -0.001 | -0.911 | -6.85 | — | 0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 72.6 | 63.7 | 1,216 | 3,045 | 1,351 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -485 | -2,003 | -1,050 | 1,692 | -763 |